KoVax Ltd - Specializes in Aqua culture vaccines development and Manufacturing

Updates:

We are very proud to inform that our project, Eureka Label E! 5888 KHV-CIM, years 2010 - 2012, was endorsed by EUREKA

KV3 Marker - KV3 be distinguished from CyHV3 (KHV) wild type virus

KV3 - Frequent asked questions

10 things you should know about Kovax

Publication on Kovax as appeared in KOI Magazine

KoVax Ltd - Specializes in Aqua culture vaccines development and manufacturing

KoVax Ltd.’s objective is to conduct research that facilitates the development of effective vaccines in the Aqua culture world.

The company manufactures and is the patent owner of KV3 vaccine (with marker) against CyHV3 (KHV) for KOI and Common Carp.
KoVax is the only company in the world that produces and markets an efficient and safe vaccine against CyHV3 (KHV ) disease - KV3